Hot Pursuit     02-Jan-24
Biocon Ltd soars 3.74%, rises for third straight session
Biocon Ltd is quoting at Rs 265.1, up 3.74% on the day as on 12:49 IST on the NSE. The stock is up 0.65% in last one year as compared to a 18.64% gain in NIFTY and a 36.1% gain in the Nifty Pharma index.

Biocon Ltd is up for a third straight session in a row. The stock is quoting at Rs 265.1, up 3.74% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.51% on the day, quoting at 21632. The Sensex is at 71811.63, down 0.64%. Biocon Ltd has risen around 10.16% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has risen around 6.02% in last one month and is currently quoting at 16858.75, up 2.06% on the day. The volume in the stock stood at 121.81 lakh shares today, compared to the daily average of 36.37 lakh shares in last one month.

The benchmark January futures contract for the stock is quoting at Rs 266.2, up 3.4% on the day. Biocon Ltd is up 0.65% in last one year as compared to a 18.64% gain in NIFTY and a 36.1% gain in the Nifty Pharma index.

The PE of the stock is 0 based on TTM earnings ending September 23.

Previous News
  Biocon jumps after receiving SAHPRA approval for Tacrolimus capsules
 ( Hot Pursuit - 22-Apr-24   11:39 )
  Biocon inks deal with Tabuk Pharma to commercialize GLP -1 products in Middle East
 ( Hot Pursuit - 27-Sep-24   11:03 )
  Biocon appoints Interim CFO
 ( Corporate News - 11-Jun-24   17:16 )
  Biocon AGM scheduled
 ( Corporate News - 17-May-24   13:47 )
  Biocon’s Andhra Pradesh facility gets 3 USFDA observations
 ( Hot Pursuit - 15-Jun-24   16:32 )
  Biocon's Malaysia facility gets OAI status from USFDA
 ( Hot Pursuit - 18-Oct-23   08:42 )
  Biocon to hold AGM
 ( Corporate News - 26-May-23   16:49 )
  Biocon Biologics' Malaysian unit enters Malaysia Book of Record
 ( Corporate News - 05-Aug-22   11:14 )
  Biocon gains as arm takes over Viatris' biosimilar biz in over 70 countries
 ( Hot Pursuit - 06-Jul-23   12:03 )
  Biocon's biologics arm concludes multi-billion-dollar acquisition of Viatris' biosimilars business
 ( Hot Pursuit - 30-Nov-22   11:47 )
  Biocon consolidated net profit rises 105.19% in the March 2021 quarter
 ( Results - Announcements 29-Apr-21   08:17 )
Other Stories
  Tata Motors total sales drop 11% YoY in Sept’24
  01-Oct-24   15:33
  Vipul Organics hits all-time high after board OKs Rs 25 cr right issue
  01-Oct-24   15:06
  Magellanic Cloud Ltd leads losers in 'A' group
  01-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  01-Oct-24   14:45
  GE Power India rises on bagging order worth Rs 240-cr
  01-Oct-24   14:41
  Volumes jump at Caplin Point Laboratories Ltd counter
  01-Oct-24   14:30
  TVS Motor registers 20% growth in September 2024 sales; Q2 total sales at 12.28 lakh units
  01-Oct-24   14:07
  Oil and Gas shares slide
  01-Oct-24   14:00
  Telecom shares fall
  01-Oct-24   14:00
  Real Estate stocks slide
  01-Oct-24   14:00
Back Top